TYRP1 and Dravet syndrome: While reducing the abundance of CSTB increased CatB activity in disomic human fibroblasts and mouse brain, this effect is not replicated in the presence of trisomy 21, suggesting that CSTB gene dose does not contribute to the regulation of CatB activity in people who have DS.